EAM
GSK icon

EverPoint Asset Management’s GSK GSK Stock Holding History

EverPoint Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-120,000
Closed -$6.05M – 459
2015
Q4 		$6.05M Buy
+120,000
New +$6.12M 0.13% 217

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EverPoint Asset Management's GSK Position: Q1 2016 in Review

EverPoint Asset Management sold out of GSK (GSK) in Q1 2016, closing a stake of 120,000 shares — an estimated $6.05M sold.

EverPoint Asset Management first reported a position in GSK in Q4 2015 and held it in 1 quarter. The position peaked at $6.05M in Q4 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • EverPoint Asset Management reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 120,000 GSK shares in Q1 2016, an estimated $6.05M.
  • EverPoint Asset Management first reported a position in GSK in Q4 2015 and held it in 1 quarter.
  • EverPoint Asset Management's GSK position peaked at $6.05M in Q4 2015.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.